Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02498821 · ClinicalTrials.gov registry record · NA
Time and Motion Related to PICC Insertion Process and Catheter Tip Confirmation
A NA study of Indication for PICC Placement, sponsored by C. R. Bard.
- Completed
- Registry status
- NA
- Development phase
- 120
- Enrollment target
- 4
- Study locations
NCT02498821: Completed NA study of Indication for PICC Placement, sponsored by C. R. Bard.
NCT02498821 is a NA study of Indication for PICC Placement that has completed, run by C. R. Bard. The registered enrollment target is 120 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). The trial reports 4 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02498821, a NA study of Indication for PICC Placement, has completed, sponsored by C. R. Bard.
- COMPLETED
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
- 4
- Study locations
Study Summary
The purpose of the study is to evaluate differences in the time and costs between Sherlock 3CG® TCS and Chest X-ray to confirm the location of a Peripherally Inserted Central Catheter (PICC).
Conditions Studied
Interventions
- DEVICE Chest X-ray
- DEVICE Sherlock 3CG® TCS
- PROCEDURE Peripherally Inserted Central Catheter (PICC)
Study Locations (4)
Maryland
- University of Maryland - Baltimore - Baltimore
- Peninsula Regional Medical Center - Salisbury
Florida
- Florida Hospital - Maitland
New York
- Unity Hospital - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2015-05 |
| Est. Completion | 2016-05 |
| Phase | NA |
What the finished NCT02498821 record still lists
NCT02498821 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).
The record links to 1 condition, with Indication for PICC Placement appearing as the primary indexed condition, and to 3 interventions - of which Chest X-ray is the first listed.
NCT02498821 reports a single indexed study location in Maryland, Florida, New York.
Frequently Asked Questions
What is clinical trial NCT02498821 about?
NCT02498821 is a clinical study titled "Time and Motion Related to PICC Insertion Process and Catheter Tip Confirmation". The purpose of the study is to evaluate differences in the time and costs between Sherlock 3CG® TCS and Chest X-ray to confirm the location of a Peripherally Inserted Central Catheter (PICC).
What is the current status of trial NCT02498821?
This trial is currently completed. It is a NA study. The enrollment target is 120 participants. The study started on 2015-05. Estimated completion is 2016-05.
What conditions does trial NCT02498821 study?
This clinical trial studies the following conditions: Indication for PICC Placement.
What interventions are being tested in trial NCT02498821?
The interventions under investigation include: Chest X-ray (DEVICE), Sherlock 3CG® TCS (DEVICE), Peripherally Inserted Central Catheter (PICC) (PROCEDURE).
Who is sponsoring clinical trial NCT02498821?
This trial is sponsored by C. R. Bard, which has 75 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02498821 being conducted?
This trial has 4 study locations across Florida, Maryland, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02498821's enrollment target sits among peer trials
120 762nd of 2000 higher than 1,198 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia